Andrés Pizzorno

Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates

Pauline Maisonnasse, Jérémie Guedj, Vanessa Contreras et al. · Nature · 2020 · 361 citations · Full text

Medicine, Infectious Diseases, Pharmacology +10

Characterization and Treatment of SARS-CoV-2 in Nasal and Bronchial Human Airway Epithelia

Andrés Pizzorno, Blandine Padey, Thomas Julien et al. · Cell Reports Medicine · 2020 · 240 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Timing of Antiviral Treatment Initiation is Critical to Reduce SARS‐CoV‐2 Viral Load

António Gonçalves, Julie Bertrand, Ruian Ke et al. · CPT Pharmacometrics & Systems Pharmacology · 2020 · 237 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +15

In vitro evaluation of antiviral activity of single and combined repurposable drugs against SARS-CoV-2

Andrés Pizzorno, Blandine Padey, Julia Dubois et al. · Antiviral Research · 2020 · 172 citations · Full text

Medicine, Infectious Diseases, Pharmacology +16

Generation and Characterization of Recombinant Pandemic Influenza A(H1N1) Viruses Resistant to Neuraminidase Inhibitors

Andrés Pizzorno, Xavier Bouhy, Yacine Abed et al. · The Journal of Infectious Diseases · 2010 · 158 citations · Full text

Life Sciences, Infectious Diseases, Pharmacology +16